Does DUPILUMAB Cause Lymphadenopathy? 760 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 760 reports of Lymphadenopathy have been filed in association with DUPILUMAB (Dupixent). This represents 0.2% of all adverse event reports for DUPILUMAB.
760
Reports of Lymphadenopathy with DUPILUMAB
0.2%
of all DUPILUMAB reports
10
Deaths
78
Hospitalizations
How Dangerous Is Lymphadenopathy From DUPILUMAB?
Of the 760 reports, 10 (1.3%) resulted in death, 78 (10.3%) required hospitalization, and 8 (1.1%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 760 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DOXORUBICIN (705)
VINCRISTINE (649)
VENETOCLAX (593)
Which DUPILUMAB Alternatives Have Lower Lymphadenopathy Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE